AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Operating margin (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.57T
P/E ratio
18.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 20252.1+34.87%
Mar 31, 20241.6-81.84%
Mar 31, 20238.8-27.07%
Mar 31, 202212+10.31%
Mar 31, 202110.9-41.95%
Mar 31, 202018.8+0.46%
Mar 31, 201918.7-1899.75%
Mar 31, 2018-1-187.23%
Mar 31, 20171.2+192.06%
Mar 31, 20160.4-88.54%
Mar 31, 20153.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)